• Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer and cosmetic procedures, including over the counter approval of sunscreen ingredients; legislative issues related to the use of telehealth services and patient protections. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues. Advocacy on Skin Cancer and the National Cancer Moonshot.
• Tax on indoor tanning services.
• Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.
• Issues related to skin cancer treatment funding in FY24 MILCON/VA H.R. 4366 and S.2127and Defense appropriations H.R.4365 and S.2587.

Duration: June 15, 2009 to present

General Issues: Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Budget/Appropriations, Small Business

Spending: about $2,200,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2009: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Management & Budget (OMB)